DBV Technologies S.A.
10-K
March 26, 2026
Key Highlights
- Successfully completed patient enrollment for the VITESSE Phase 3 clinical trial...
- Clear roadmap for FDA approval submissions in 2026 for children aged 1–7.
- Innovative Viaskin Peanut patch technology offers a non-bloodstream delivery met...
Read Analysis
🤖 AI Generated